Page last updated: 2024-12-08

cyclopropenone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cyclopropenone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cyclopropenone : Three-membered alicyclic ketones containing a single C=C double bond. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID137779
MeSH IDM0332858

Synonyms (13)

Synonym
unii-5mpz6qz6zf
cyclopropenone
5mpz6qz6zf ,
inchi=1/c3h2o/c4-3-1-2-3/h1-2
cycloprop-2-en-1-one
2-cyclopropen-1-one
FT-0656921
2961-80-0
A819977
1-cycloprop-2-enone
GGRQLKPIJPFWEZ-UHFFFAOYSA-N
DTXSID50183796
Q21099673
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (43)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (2.33)18.2507
2000's15 (34.88)29.6817
2010's16 (37.21)24.3611
2020's11 (25.58)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.29

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.29 (24.57)
Research Supply Index3.78 (2.92)
Research Growth Index5.40 (4.65)
Search Engine Demand Index39.34 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.29)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (4.65%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other41 (95.35%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]